Acro Biomedical Co., Ltd. (ACBM): Total Liabilities

Annual figures by period end, from SEC filings.

$326.9K
As of 2024-12-31
+40.7%
3-year compound annual growth
+19.5%
5-year compound annual growth
2015-09-30: $8252016-09-30: $17.3K2017-09-30: $37.0K2018-09-30: $240.7K2019-09-30: $195.8K2019-12-31: $133.9K2020-12-31: $312.2K2021-12-31: $117.4K2022-12-31: $201.1K2023-12-31: $315.5K2024-12-31: $326.9K$326.9K
2015-09-30 Total Liabilities (USD) 2024-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2024-12-31$326.9K+3.6%2025-07-24, Balance as of period end
2023-12-31$315.5K+56.9%2025-07-24, Balance as of period end
2022-12-31$201.1K+71.4%2025-07-18, Balance as of period end
2021-12-31$117.4K-62.4%2023-07-21, Balance as of period end
2020-12-31$312.2K+133.2%2022-04-15, Balance as of period end
2019-12-31$133.9Kn/a2021-04-02, Balance as of period end
2019-09-30$195.8K-18.6%2020-01-07, Balance as of period end
2018-09-30$240.7K+550.8%2020-01-07, Balance as of period end
2017-09-30$37.0K+113.4%2018-12-28, Balance as of period end
2016-09-30$17.3Kn/m2018-01-16, Balance as of period end
2015-09-30$825n/a2016-12-16, Balance as of period end